Dexter's first safety trials and validation
From the news:
- Around 20 surgeons and 20 nurses from leading European hospitals, across urology, gynaecology and general surgery participated in Dexter validation end of February and early March 2020
- Surgical teams successfully performed surgical procedures using Dexter, including draping, docking, suturing, dissection, switching between laparoscopy and robotics, removal and emergency scenarios
Distalmotion, a Swiss-based medical device company
removing the complexity out of robotic surgery to fast track its
widespread adoption in minimally invasive surgical care, announced today
the successful validation of its surgical robot Dexter. By confirming
that it is safe for use and meets surgeons and nurses requirements,
Dexter successful validation brings Distalmotion surgical robot Dexter
one-step closer to commercialization.
The company announced that end of February and early March 2020
17 surgeons and 16 nurses from leading European hospitals, across
urology, gynaecology and general surgery, participated in Dexter
validation first step. In this phase, surgical teams successfully
performed surgical procedures using Distalmotion's surgical robot,
including draping, docking, use, switching between laparoscopy and
robotics, removal and emergency scenarios. This phase confirmed Dexter
performs as intended and can be used safely. As a second step, 2
urologists and 3 general surgeons performed 8 full procedures: 1
Nissen-fundoplication, 1 partial cystectomy, 3 cholecystectomies, 1
radial nephrectomy, 1 partial gastrectomy and 1 sigmoid mobilization.
This second phase confirmed Dexter's full performance for procedures on
life tissues.
Speaking about Dexter successful validation early March 2020, Michael Friedrich,
Distalmotion CEO, said, "The Dexter validation is a major milestone
towards the go-to-market of Distalmotion's surgical robot. We are now
setting our sight on the final testing and verification before
regulatory approval and commercialisation. Today's announcement is
bringing us one step closer to our vision of establishing a new global
standard of care allowing everyone to access the benefits of robotic
surgery."
Source: Dexter
Comments